When will a generic version of teflaro be available?

When does the patent for Teflaro expire?

Teflaro contains the active ingredient ceftaroline fosamil. Its composition of matter patent expires in 2025. The regulatory exclusivity period protecting the brand also ends that year. Both timelines point to possible generic entry in 2025 or shortly after.

Why are companies challenging this patent?

Generic manufacturers filed Paragraph IV certifications against the remaining patents listed in the FDA Orange Book for Teflaro. Those challenges target patents covering crystal forms and methods of use. The outcome of these litigations will determine whether generics can launch at risk or must wait for full patent expiry.

Can biosimilars enter before patent expiry?

Teflaro is a small-molecule antibiotic, not a biologic. Biosimilars apply only to biologics. Generic versions of ceftaroline fosamil will follow the ANDA route once all relevant patents expire or are invalidated.

How does Teflaro compare with vancomycin?

Teflaro shows activity against methicillin-resistant Staphylococcus aureus (MRSA) and some multidrug-resistant Gram-positive bacteria. It also covers some Gram-negative organisms that vancomycin does not. Data show comparable clinical cure rates in skin infections and pneumonia, but its broad spectrum requires different dosing adjustments in renal impairment.

What side effects are patients asking about?

Patients frequently report diarrhea, nausea, and headache. Serious adverse events include Clostridioides difficile colitis and hypersensitivity reactions. Renal impairment requires dose adjustments to avoid further complications.

When does exclusivity expire?

Regulatory exclusivity for Teflaro ended in 2025. The main composition-of-matter patent also expires in 2025. Any remaining patents covering crystal forms and methods of use are already under challenge.

Who makes Teflaro?

Teflaro is marketed by Allergan, an AbbVie company. AbbVie holds the patents and licenses the rights to the active ingredient ceftaroline fosamil.

What price range does Teflaro show on price trackers?

Teflaro shows high acquisition cost. Brand pricing sits around several hundred dollars per day of therapy. Generic entry would likely bring substantial price drops, but exact savings figures will appear only once generics reach the market.

How does Teflaro interact with renal impairment?

Teflaro requires dose reduction in patients with moderate to heavy renal impairment. Current data indicate that 400 mg every 12 hours for patients with CrCl 30–50 ml/min and 300 mg every 12 hours for patients with CrCl 30–15 ml/min keep the drug safe and safe in those patients.

How long does the drug stay in the rad

How long does the drug stay in the rad